PARP1 and ovarian cancer: Patel et al. examined the role of PARP1 in NHEJ and whether the inhibition of PARP1 in HR-deficient ovarian cancer cells would lead to dysfunction in the NHEJ DNA repair pathway because HR-deficient cancers cells rely on the NHEJ pathway to repair DNA double-strand breaks [157].